NEW YORK (AP) — Shares of drug developer Kadmon Holdings tumbled Wednesday after its initial public offering priced far below the company's estimates. Kadmon said its offering of 6.25 million shares priced at $12 a share, raising $75 million in total.Read more on NewsOK.com